Top

Published in:

Open Access 01-05-2020 | Chronic Myeloid Leukemia | Letter to the Editor

A 19-year-old patient with atypical chronic myeloid leukemia

Authors: Philipp Ernst, Björn Engmann, Jochen J. Frietsch, Ulf Schnetzke, Sebastian Scholl, Bernhard Theis, Hans H. Kreipe, Thomas Ernst, Anita Glaser, Torsten Haferlach, Thilo Koch, Andreas Hochhaus, Inken Hilgendorf

Published in: Annals of Hematology | Issue 5/2020

Excerpt

Dear Editor, …

Gotlib J (2017) How I treat atypical chronic myeloid leukemia. Blood 129(7):838–845. https://doi.org/10.1182/blood-2016-08-693630 CrossRefPubMed

Gotlib J, Maxson JE, George TI, Tyner JW (2013) The new genetics of chronic neutrophilic leukemia and atypical CML: implications for diagnosis and treatment. Blood 122(10):1707–1711. https://doi.org/10.1182/blood-2013-05-500959 CrossRefPubMedPubMedCentral

Wang SA, Hasserjian RP, Fox PS, Rogers HJ, Geyer JT, Chabot-Richards D, Weinzierl E, Hatem J, Jaso J, Kanagal-Shamanna R, Stingo FC, Patel KP, Mehrotra M, Bueso-Ramos C, Young KH, Dinardo CD, Verstovsek S, Tiu RV, Bagg A, Hsi ED, Arber DA, Foucar K, Luthra R, Orazi A (2014) Atypical chronic myeloid leukemia is clinically distinct from unclassifiable myelodysplastic/myeloproliferative neoplasms. Blood 123(17):2645–2651. https://doi.org/10.1182/blood-2014-02-553800 CrossRefPubMedPubMedCentral

Onida F, de Wreede LC, van Biezen A, Eikema DJ, Byrne JL, Iori AP, Schots R, Jungova A, Schetelig J, Finke J, Veelken H, Johansson JE, Craddock C, Stelljes M, Theobald M, Holler E, Schanz U, Schaap N, Bittenbring J, Olavarria E, Chalandon Y, Kroger N (2017) Allogeneic stem cell transplantation in patients with atypical chronic myeloid leukaemia: a retrospective study from the ChronicMalignancies Working Party of the European Society for Blood and Marrow Transplantation. Br J Haematol 177(5):759–765. https://doi.org/10.1111/bjh.14619 CrossRefPubMed

Meggendorfer M, Bacher U, Alpermann T, Haferlach C, Kern W, Gambacorti-Passerini C, Haferlach T, Schnittger S (2013) SETBP1 mutations occur in 9% of MDS/MPN and in 4% of MPN cases and are strongly associated with atypical CML, monosomy 7, isochromosome i(17)(q10), ASXL1 and CBL mutations. Leukemia 27(9):1852–1860. https://doi.org/10.1038/leu.2013.133 CrossRefPubMed

Malcovati L, Karimi M, Papaemmanuil E, Ambaglio I, Jadersten M, Jansson M, Elena C, Galli A, Walldin G, Della Porta MG, Raaschou-Jensen K, Travaglino E, Kallenbach K, Pietra D, Ljungstrom V, Conte S, Boveri E, Invernizzi R, Rosenquist R, Campbell PJ, Cazzola M, Hellstrom Lindberg E (2015) SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts. Blood 126(2):233–241. https://doi.org/10.1182/blood-2015-03-633537 CrossRefPubMedPubMedCentral

Balgobind BV, Van Vlierberghe P, van den Ouweland AM, Beverloo HB, Terlouw-Kromosoeto JN, van Wering ER, Reinhardt D, Horstmann M, Kaspers GJ, Pieters R, Zwaan CM, Van den Heuvel-Eibrink MM, Meijerink JP (2008) Leukemia-associated NF1 inactivation in patients with pediatric T-ALL and AML lacking evidence for neurofibromatosis. Blood 111(8):4322–4328. https://doi.org/10.1182/blood-2007-06-095075 CrossRefPubMed

Cazzola M, Della Porta MG, Malcovati L (2013) The genetic basis of myelodysplasia and its clinical relevance. Blood 122(25):4021–4034. https://doi.org/10.1182/blood-2013-09-381665 CrossRefPubMedPubMedCentral

Eisfeld AK, Kohlschmidt J, Mrozek K, Mims A, Walker CJ, Blachly JS, Nicolet D, Orwick S, Maharry SE, Carroll AJ, Powell BL, Kolitz JE, Wang ES, Stone RM, de la Chapelle A, Byrd JC, Bloomfield CD (2018) NF1 mutations are recurrent in adult acute myeloid leukemia and confer poor outcome. Leukemia 32(12):2536–2545. https://doi.org/10.1038/s41375-018-0147-4 CrossRefPubMedPubMedCentral

Title: A 19-year-old patient with atypical chronic myeloid leukemia
Authors: Philipp Ernst
Björn Engmann
Jochen J. Frietsch
Ulf Schnetzke
Sebastian Scholl
Bernhard Theis
Hans H. Kreipe
Thomas Ernst
Anita Glaser
Torsten Haferlach
Thilo Koch
Andreas Hochhaus
Inken Hilgendorf
Publication date: 01-05-2020
Publisher: Springer Berlin Heidelberg
Keywords: Chronic Myeloid Leukemia
Fluorescence in Situ Hybridization
Trisomy
Published in: Annals of Hematology / Issue 5/2020
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI: https://doi.org/10.1007/s00277-020-03992-w

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

A 19-year-old patient with atypical chronic myeloid leukemia

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 5/2020

The clinical significance of the prognostic nutritional index in very elderly patients over 80 years of age with diffuse large B-cell lymphoma

Current IST-free/relapse-free survival as a new endpoint after allogeneic hematopoietic stem cell transplantation

Histological and magnified endoscopic evaluation of villous atrophy in gastrointestinal graft-versus-host disease

Rectal involvement in pre-early T acute lymphoblastic leukemia

Real-world effectiveness and safety of ixazomib-lenalidomide-dexamethasone in relapsed/refractory multiple myeloma

Serum albumin and C-reactive protein as significant predictors of non-relapse mortality in lower gastrointestinal graft-versus-host disease

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page